NanoHive Medical

United States - Woburn, Massachusetts

• 06/08/2024
• Series C
• $7,000,000

NanoHive Medical (formerly HD LifeSciences) created the proprietary, biomimetic Soft Titanium technology, which clearly distinguishes their products in the $1.9B spinal interbody fusion device market. The Hive™ portfolio of interbody fusion devices provides surgeons and their patients with the ideal features that lead to consistently strong fusion constructs and efficacious clinical experiences.

Related People

Patrick O.Founder

United States - Greater Boston

Medical Device and Biosurgery executive leader with over 25 years of consistently successful experience at pre-commercial and commercial stages companies. Success in the medical device, orthobiologics, and biomaterials industries with technologies in the orthopedic, spine, neurosurgery, sports medicine, interventional radiology markets. Extensive team-building, executive management, strategy development, sales and marketing management, strategic partnership development, distribution channel development, Board management, start-up, turn around, and fund raising (over $90M) experience.

LinkedIn https://www.linkedin.com/in/patrick-o-291487b/